Every material Form 8-K Genasys Inc. has filed with the SEC since September 14, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Genasys Inc. published preliminary, unaudited results for its fiscal fourth quarter and full fiscal year 2026, ended September 30, 2026. Full fiscal year revenue is expected to range from $60.5 million to $62.0 million, with adjusted EBITDA of $7.2 million to $8.2 million, and the company says the audit has not yet concluded, so final figures may differ materially. The filing gives no prior-year comparison, and complete results are due December 15, 2026.
Full fiscal year 2026 revenue expected at $60.5 million to $62.0 million; fourth quarter revenue expected at $20.5 million to $22.0 million
Full fiscal year adjusted EBITDA expected at $7.2 million to $8.2 million; full year operating income expected at $3.4 million to $3.7 million
Full fiscal year gross margin expected at 58% to 60%; fourth quarter gross margin expected at 66% to 68%
Complete results and conference call scheduled for December 15, 2026; the company says the year-end audit has not yet concluded
Genasys said it repaid in full the unsecured term loan from Maran Partners Fund, LP, with the final payment of principal and accrued interest made on October 23, 2026. The company says it now has no remaining obligations under that loan and can focus loan servicing on its secured term loan, where it made its first monthly amortization payment on October 1, 2026.
Original borrowing of $4.3 million from Maran Partners on June 9, 2026
Loan amended September 14, 2026, with a partial repayment at that time
Final payment of remaining principal and accrued interest made October 23, 2026
CFO Cassandra Monteon said the company expects to repay the secured term loan on schedule
Genasys Inc. entered into a First Amendment to its loan agreement with Maran Partners Fund, LP, dated September 14, 2026, and reported it under Item 2.03 as a direct financial obligation. The filing does not state the amendment's amount, interest rate, maturity or changed terms in the text provided, so shareholders cannot yet judge its size or cost from this document.
Amendment is dated September 14, 2026, between Genasys Inc. and Maran Partners Fund, LP (Exhibit 10.1).
The filing is made under Items 1.01, 2.03 and 9.01; the Item 1.01 disclosure it incorporates is not included in the text provided.
No loan amount, interest rate or revised repayment terms are stated in the text provided.
Filing was signed by Chief Financial Officer Cassandra L. Hernandez-Monteon.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Genasys Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →